Ponatinib
Drug timelines are a Plus or Pro feature.
28 regulatory and trial events tracked for Ponatinib, covering 2016-03-17 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors [Phase 1, Phase 2]